Detail akcie Bionano Genom Rg online

Business Summary: Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Financial Summary: BRIEF: For the nine months ended 30 September 2025, BioNano Genomics Inc revenues decreased 9% to $20.6M. Net loss decreased 80% to $18.5M. Revenues reflect Services and other segment decrease of 60% to $1.3M, Instruments segment decrease of 30% to $3.7M, Americas segment decrease of 17% to $8.8M, Asia Pacific segment decrease of 27% to $1.8M. Lower net loss reflects Intangible assets and other long-lived a decrease from $19.5M (expense) to $0K.